Molecular characterization of 13 patients with PIK3CA‐related overgrowth spectrum using a targeted deep sequencing approach
- 10 November 2023
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (3)
Abstract
Activating variants in the PIK3CA gene cause a heterogeneous spectrum of disorders that involve congenital or early‐onset segmental/focal overgrowth, now referred to as PIK3CA‐related overgrowth spectrum (PROS). Historically, the clinical diagnoses of patients with PROS included a range of distinct syndromes, including CLOVES syndrome, dysplastic megalencephaly, hemimegalencephaly, focal cortical dysplasia, Klippel–Trenaunay syndrome, CLAPO syndrome, fibroadipose hyperplasia or overgrowth, hemihyperplasia multiple lipomatosis, and megalencephaly capillary malformation‐polymicrogyria (MCAP) syndrome. MCAP is a sporadic overgrowth disorder that exhibits core features of progressive megalencephaly, vascular malformations, distal limb malformations, cortical brain malformations, and connective tissue dysplasia. In 2012, our research group contributed to the identification of predominantly mosaic, gain‐of‐function variants in PIK3CA as an underlying genetic cause of the syndrome. Mosaic variants are technically more difficult to detect and require implementation of more sensitive sequencing technologies and less stringent variant calling algorithms. In this study, we demonstrated the utility of deep sequencing using the Illumina TruSight Oncology 500 (TSO500) sequencing panel in identifying variants with low allele fractions in a series of patients with PROS and suspected mosaicism: pathogenic, mosaic PIK3CA variants were identified in all 13 individuals, including 6 positive controls. This study highlights the importance of screening for low‐level mosaic variants in PROS patients. The use of targeted panels with deep sequencing in clinical genetic testing laboratories would improve diagnostic yield and accuracy within this patient population.Keywords
Funding Information
- Canadian Institutes of Health Research (FDN‐154279)
- Genome Alberta
- Genome British Columbia
- Genome Canada
- Génome Québec
- Ontario Genomics Institute
- Ontario Research Foundation
This publication has 30 references indexed in Scilit:
- GEMINI: Integrative Exploration of Genetic Variation and Genome AnnotationsPLOS Computational Biology, 2013
- Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CANature Genetics, 2012
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesNature Genetics, 2012
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES SyndromeThe American Journal of Human Genetics, 2012
- A Mosaic Activating Mutation inAKT1Associated with the Proteus SyndromeNew England Journal of Medicine, 2011
- A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial CarcinomasClinical Cancer Research, 2011
- Rare cancer-specific mutations in PIK3CA show gain of functionProceedings of the National Academy of Sciences, 2007
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- Macrocephaly-Cutis marmorata telangiectatica congenita: A distinct disorder with developmental delay and connective tissue abnormalitiesAmerican Journal of Medical Genetics, 1997
- Lethal genes surviving by mosaicism: A possible explanation for sporadic birth defects involving the skinJournal of the American Academy of Dermatology, 1987